Investment Committee Summary
| Rating | HOLD |
| Internal 5-tier | HOLD |
| Classification · conviction | quality defensive · medium |
| Evidence | 8/8 load-bearing inputs sourced |
| Triangulated fair value | $57.14 (-11% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $71.18 (+11% vs spot · 12m PWEV) |
| Next catalyst | 2026-10-16 — Quarterly earnings |
| Primary thesis-break | Total revenue growth (YoY) < 0.01 (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: HOLD
Internal 5-tier: HOLD · quality defensive · analyst conviction: medium
| Metric | Value |
|---|---|
| Current Price | $63.90 |
| Triangulated Fair Value | $57.14 (-11% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $71.18 (+11% vs spot · 12m PWEV) |
| Forward P/E | 12.5x |
| Market Cap | $27B |
| 52-Week Range | $47.95–$75.33 (intraday high and low over the trailing 52 weeks of the stock's own daily bars) |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across four weighted anchors — an intrinsic DCF, a scenario-weighted PWEV, a Monte Carlo median (Student-t + regime switching) and a peer P/E re-rate. Anchors are blended at fixed declared weights, each counted separately; the Monte Carlo and the scenario PWEV all rest on the same base multiple, so where they agree it is partly by construction — not independent corroboration. Figures reconciled to Alpha Vantage 2026-10-12. Each chart below sits with the part of the thesis it evidences.
General research, published identically to every reader. Not personal financial advice. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Next catalyst |
|---|---|---|---|
| 62.7/100 (71st pct) | +12% 1yr expected | Hold | 3d — Quarterly earnings |
Full breakdown — conviction components, probability-return distribution, decision rules, factor & portfolio interaction and the catalyst timeline — in the Decision Support sections below. Model output for research; not personal financial advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: HOLD
Balanced: triangulated fair value $57.14 (-11% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Investment Thesis
At $63.90 (13 October 2026) Citizens trades at about 13x forward earnings, a premium to the regional-bank peer median, and above stated book value despite a trailing return on equity that has run below its cost of equity. The market is paying for a mid-cycle return-on-tangible-equity recovery plus continued buybacks. The engine is less generous. Probability-weighted value is $71.18 and the twelve-month target $71.25, but the blended anchor triangulates to $57.14 — a gap of -11% that leaves the shares fairly valued against the anchor set. Most of the simulated variance sits in the multiple rather than the earnings line, so this is a rates-and-sentiment position more than an earnings-growth one, and the base earnings path supports the price only if the premium multiple holds. HOLD follows: the recovery is already in the price, the shares have run a long way off their 52-week low, and the combined bear weight in the tree is substantial. The most damaging risk is a joint credit-cost and net-interest-margin print, where the structural scenario target sits below the 52-week low.
Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.
The dashboard below is the whole argument on one page: spot ($63.90) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural bear needs no recession call to work. Citizens earns a return on equity below its cost of equity; if credit costs normalise upward while deposit competition keeps funding expensive, the net interest margin compresses at the same moment provisioning rises. A tightening of capital rules for large regional banks would then halt the buyback, which is the main per-share earnings support. On that path earnings fall materially and the market re-rates a franchise earning below its cost of equity to a multiple well beneath 13x, which is how the structural target lands below the 52-week low. No link in that chain is exotic; each has a precedent in the regional-bank stress of 2008 and again in 2023. The recovery premium embedded in the current price has already been spent.
Key Debate
P/E Multiple explains 87% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
What the Market Is Pricing In
At the current price, the market pays 12.1× consensus forward EPS, and a peer median 12.0×.
Variant perception: the house view is below-consensus, and the thesis is primarily FCF-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 9.2 | 8.3 | High |
| EPS | 5.3 | 5.1 | Medium |
| Target price | 79.3 | 71.2 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — Credit Cycle / NIM Compression / Regulation' downside ($31.40) to a 'Bull — Re-Rate / Buybacks' bull case ($127); the probability-weighted blend (PWEV $71.18) is +11% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Credit Cycle / NIM Compression / Regulation | 20% | $31.40 | -51% |
| Recession — Heavy Provisioning | 17% | $53.40 | -16% |
| Base — Mid-Cycle ROTCE | 35% | $74.00 | +16% |
| Growth — Rate Tailwind / Loan & Fee Growth | 20% | $100 | +57% |
| Bull — Re-Rate / Buybacks | 8% | $127 | +99% |
| Probability-Weighted (PWEV, after SBC dilution) | — | $71.18 | +11% |
SBC charge: scenario targets are gross per-share prices; the PWEV is reduced by one year of stock-based-compensation dilution (0.4% of shares, on SBC ≈ 1% of revenue), trimming the gross PWEV of $71.47 to $71.18 (-0.4%). SBC is charged once, as dilution — never also deducted from FCF.
Scenario rationale — the driver path behind every target:
- Structural — Credit Cycle / NIM Compression / Regulation (20%, $31.40). Structural impairment — credit cycle / NIM compression / regulation: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Recession — Heavy Provisioning (17%, $53.40). Cyclical downturn — earning-asset growth + net interest spread + credit costs + fee income weakens for 1–2 years before normalising.
- Base — Mid-Cycle ROTCE (35%, $74.00). Mid-cycle — normalised earning-asset growth + net interest spread + credit costs + fee income; disciplined capital allocation; steady returns.
- Growth — Rate Tailwind / Loan & Fee Growth (20%, $100). Upside — rate tailwind + loan & fee growth lifts earnings above mid-cycle; the multiple expands modestly.
- Bull — Re-Rate / Buybacks (8%, $127). Upside tail — sustained tight conditions or a structural re-rate on rate tailwind + loan & fee growth.
Valuation Triangulation
Four weighted anchors — an intrinsic dcf, a scenario-weighted pwev, a monte carlo median (student-t + regime switching) and a peer p/e re-rate — read them with their basis in mind. The Monte Carlo, the scenario PWEV, any DCF's exit-multiple terminal and any peer re-rate key off a market multiple, so they are not independent; only a DCF's explicit-period cash flows are multiple-free, and its terminal usually carries most of its value. The discipline is to read the spread, not to treat four numbers as four independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $65.33 | +2% | 20% (declared 15%) |
| Peer P/E re-rate | multiple | $61.32 | -4% | 13% (declared 10%) |
| Peer EV/Revenue re-rate | multiple | $120 | +87% | 0% — cross-check only |
| Scenario PWEV | multiple | $71.18 | +11% | 33% (declared 25%) |
| Justified P/B (ROE-based) | book value × ROE | $36.84 | -42% | 34% (declared 35%) |
| Triangulated (weighted) | — | $57.14 | -11% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts is not computed, so 15% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Book Value, ROE & Capital Returns
For a bank or insurer the cash-flow DCF is the wrong intrinsic anchor — capital is the product. Value is set by return on equity vs cost of equity against book value: the Gordon-justified multiple is P/B = (ROE − g) / (COE − g).
| Metric | Value |
|---|---|
| Book value / share | $56.48 |
| Return on equity (ROE) | 7.7% |
| Cost of equity (assumed) | 10.0% |
| Current P/B | 1.13x |
| Justified P/B (ROE-based) | 0.65x |
| Justified value / share | $36.84 (-42%) |
ROE of 7.7% falls short of the ~10% cost of equity — which is why a sub-1x justified P/B of 0.65x (vs 1.13x current) is warranted. The justified value sits -42% vs spot; that gap, plus the credit / underwriting cycle in the scenarios, is the debate. The Monte Carlo and scenario PWEV carry the earnings (P/E) view; this block carries the book-value view.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $65.33 and 53% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (87% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
Peer benchmarking — relative value
Against its 4 peers in the same GICS sub-industry, re-rating to their median forward multiple (P/E 12.0x) implies $61.32. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 13% so market sentiment does not set the fair value.
Across all anchors the spread is 127% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| FITB | 13.4× | 5% | 8% | direct | 100% |
| HBAN | 11.1× | 5% | 41% | direct | 100% |
| MTB | 12.7× | 5% | 39% | direct | 100% |
| RF | 11.3× | 5% | 40% | direct | 100% |
Quality-weighted forward P/E: 12.1× (simple median 12.0×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $47.95–$75.33, centre $60.10 (-6% vs spot); spot sits at the 58th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV (FV ÷ price − 1) | $57.14 (-11% vs spot · triangulated FV) |
| Downside to lowest scenario (Structural — Credit Cycle / NIM Compression / Regulation) | $31.40 (-51% vs spot · bear scenario) |
| Reward-to-risk ratio | withheld — the triangulated FV is at or below spot, so there is no reward leg to divide by the risk leg |
| Discount to fair value (1 − price ÷ FV) | -12% |
| P(price > spot) — Monte Carlo | 53% |
That ratio is (triangulated FV ÷ price − 1) ÷ (1 − 'Structural — Credit Cycle / NIM Compression / Regulation' target ÷ price). 'Structural — Credit Cycle / NIM Compression / Regulation' ($31.40, probability 20%) is the lowest-target scenario in the tree, taken gross of SBC dilution. With a leg missing the ratio is withheld rather than computed from a magnitude. Bull case (Bull — Re-Rate / Buybacks): $127.
Company Overview & Business Model
Citizens Financial Group, Inc. — FINANCIAL SERVICES · BANKS - REGIONAL. Citizens Financial Group, Inc. is an American bank headquartered in Providence, Rhode Island.
Company description as supplied by Alpha Vantage; not checked against the company's filings.
How it makes money.
| Segment | Rev mix | Growth | Model op margin† | Key driver |
|---|---|---|---|---|
| Banking (NII + Fees) | 100% | +5% | 39% | earning-asset growth + net interest spread + credit costs + fee income |
† Model margin = gross margin − the opex ratio calibrated so the Monte Carlo median EPS meets the EPS target; it is not a reported operating margin.
Edge. Narrow moat. Authored moat rationale withheld pending re-authoring.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Model op margin† | Model EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Banking (NII + Fees) | $7.9B | 100% | 5% | 39% | $3.1B | 14.0x | 1% | ESTIMATE |
| † Model EBIT = revenue × the model margin, i.e. gross margin less the opex ratio the calibration solved for to meet the EPS target — not the company's reported operating income. |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | earning-asset growth + net interest spread + credit costs + fee income |
| net_debt_or_cash_b | 0.02 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.01 |
| div_yield | 0.0253 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | credit cycle / NIM compression / regulation |
| upside | rate tailwind + loan & fee growth |
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $-38.1B — net cash |
| Interest coverage (EBIT / interest) | 0.6x |
| Current ratio | 1.04x |
| Cash & ST investments | $49.4B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $2.0B |
| Buybacks / dividends | $1.0B / $0.9B |
| Total shareholder yield | 6.9% |
| Payout as % of FCF | 92.7% |
| Reinvestment (capex / OCF) | 7.9% |
| SBC as % of FCF | 5.9% |
| Allocation stance | returns-heavy |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 25.8% |
| FCF conversion (FCF / net income) | 111.3% |
| FCF yield | 7.5% |
| Capex intensity (capex / revenue) | 2.2% |
| FCF − SBC (diagnostic) | $1.9B |
| Capex split (maint / growth) | 80% / 20% — A bank has minimal physical capex; investment is technology/digital-platform and branch modernisation (maintenance-heavy) with a small growth slice for the private-bank/wealth build-out. Capital deployment runs through RWA growth, provisioning and buybacks, not capex — capex_split is therefore a technology-spend proxy. |
Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 121% — cash-backed.
Competitive Moat
Moat sources:
- Regional deposit franchise with retail/commercial relationship density across the Northeast and Midwest (funding-cost advantage vs wholesale)
- Private-bank and wealth build-out (ex-First Republic hires) adding fee income and stickier balances
- Commercial-banking and capital-markets fee platform (Citizens JMP) diversifying beyond spread income
- ABSENCE of a scale or switching-cost moat — deposits are contestable and the bank earns below its cost of equity
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q2): management +0.60 vs analyst floor +0.01 → delta +0.59 (n=44 mgmt / 30 Q&A; 85th pctile across the S&P book, z +1.1).
Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q2 | +0.60 | +0.01 | +0.59 |
| 2026Q1 | +0.54 | +0.00 | +0.54 |
| 2025Q4 | +0.44 | +0.18 | +0.26 |
| 2025Q3 | +0.31 | +0.22 | +0.10 |
News (last 365d, 1768 articles): avg ticker sentiment +0.19 (bullish 22% / bearish 3%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $79.26 (+24% vs spot · street) |
| House target | $71.25 (-10.1% vs street) |
| Sell-side coverage | 18 analysts (SB 5 / B 10 / H 3 / S 0 / SS 0; net score 0.56) |
| Consensus FY EPS | $5.29; house below (-3.4%) |
| Consensus FY revenue | $9.2B; house below (-9.6%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-10-16 (~4d) — Quarterly earnings — est. EPS $1.38 (AV EARNINGS_CALENDAR)
- 2026-10-16 (~4d) — Investor day / medium-term ROTCE and NIM target update (authored)
- 2027-03-31 (~170d) — Commercial-real-estate (office) loan-portfolio credit-migration and reserve-build read (authored)
Forecast Track Record
- EPS surprise: beat 88% of the last 8 quarters; average surprise +2.6%.
Catalyst Timeline
6 catalysts in the next 90 days (of 14 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-10-14 (in 1d) | September CPI | macro | ●● | 0.8 |
| 2026-10-16 (in 3d) | Quarterly earnings | earnings | ●●● | 0.95 |
| 2026-10-16 (in 3d) | Investor day / medium-term ROTCE and NIM target update | authored | ● | 0.7 |
| 2026-10-28 (in 15d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-12-09 (in 57d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 66d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-27 (in 106d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-03-17 (in 155d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 157d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-03-31 (in 169d) | Commercial-real-estate (office) loan-portfolio credit-migration and reserve-build read | authored | ● | 0.7 |
| 2027-04-28 (in 197d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-06-09 (in 239d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-06-18 (in 248d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-09-17 (in 339d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
_Sources: extended.catalysts, data/catalysts/
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Basel III Endgame / enhanced capital and liquidity rules for large regional banks (>$100bn category) | high (~55%) | high - higher capital requirements cap buyback capacity and lower sustainable ROTCE, the core of the equity case; ~12% of FV | 12-24m |
| Long-term-debt / TLAC and FDIC special-assessment requirements for large regionals post-2023 bank stress | medium (~40%) | medium - raises funding cost and dilutes ROTCE; ~6% of FV | 12-24m |
| CRE-concentration supervisory scrutiny and stress-test (CCAR-style) capital demands | medium (~35%) | medium - tighter CRE oversight forces reserve build and constrains lending; ~7% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Credit Cycle / NIM Compression / Regulation | A CRE/office-led credit cycle drives heavy provisioning while Basel III Endgame lifts capital requirements and NIM compresses structurally; ROTCE stays below cost of equity and the multiple de-rates below 1.0x book. | Credit losses and higher capital requirements hit together, permanently impairing the ROTCE recovery. |
| Recession — Heavy Provisioning | A recession drives a sharp provisioning cycle and loan-loss reserve build for 1-2 years before normalisation. | Provisioning that reveals structural CRE/office impairment rather than a cyclical peak. |
| Growth — Rate Tailwind / Loan & Fee Growth | A favourable rate curve lifts NII while loan and private-bank fee growth accelerate ROTCE above base. | Rate cuts compress asset yields faster than deposit costs fall, squeezing NIM. |
| Bull — Re-Rate / Buybacks | Sustained ROTCE above cost of equity plus aggressive buybacks re-rate the equity above book value. | A regulatory capital increase curtails buybacks and caps the re-rate. |
Scenario-macro rows withheld pending re-authoring: 1 carrying another cluster's vocabulary or a frozen figure — recorded in the narrative quarantine ledger.
Decision Rules (Machine-Checked)
Stance: Hold — 0 bullish / 0 bearish / 1 caution rules triggered of 6 evaluable (0 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
11.5 | no |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
11.5 | no |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.56 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
120.8 | no |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
0.99 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
1.43 | YES |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is what the model's own rules read on this name; it does not modify the published research rating, and it is not personal financial advice.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Total revenue growth (YoY) < 0.01 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Operating margin (pre-tax, total revenue basis) < 0.335 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Annualised diluted EPS (quarterly print x4) < 4.97 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Net charge-off ratio (annualised, % of average loans) > 0.6 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Share repurchase programme suspension or regulatory capital add-on = announced (single event). Buybacks are the principal per-share earnings support in the bull path. A suspension, or a binding capital requirement increase for category-IV banks, removes that support and validates the regulation limb of the structural scenario.
Fact / Inference / Speculation
- FACT: Spot $63.90; 52-week range $47.95–$75.33; engine rating HOLD; house target $71.25 (+11%). (source: Alpha Vantage 2026-10-12, 13 October 2026)
- INFERENCE: Triangulated FV $57.14 (-11% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the justified-P/B anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
62.7/100 (confidence band 46.1–79.3), 71st percentile of 928 covered names (as of 2026-10-12). Weighted composite under config ros-1.21.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 77 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | — | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 62 | 15% | upside_pct |
| growth | 53 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 88 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 61 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 22 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | — | 10% | industry_context.scenario_states |
| risk profile | 71 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Missing inputs (financial strength, macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.
Score history: 62.6 → 62.6 → 62.1 → 62.2 → 62.8 → 62.8 → 63.1 → 62.9.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — Credit Cycle / NIM Compression / Regulation | 20% | $31.40 | -50.9% | -10.2pp |
| Recession — Heavy Provisioning | 17% | $53.40 | -16.4% | -2.8pp |
| Base — Mid-Cycle ROTCE | 35% | $74.00 | +15.8% | +5.5pp |
| Growth — Rate Tailwind / Loan & Fee Growth | 20% | $100 | +57.0% | +11.4pp |
| Bull — Re-Rate / Buybacks | 8% | $127 | +98.6% | +7.9pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | +11.9% |
| Expected return net of SBC dilution | +11.4% |
| Outcome dispersion (σ, from MC p10–p90) | 32.9% |
| Expected Sharpe (rf 4%) | 0.24 |
| Downside expectation (prob-weighted loss branches) | -13.0% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | 11.9% |
| Risk-free rate | 4.49% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-10-08) |
| Beta (shrunk, 1y vs SPY) | 1.00 (as of 2026-10-12) |
| Equity risk premium | 4.5% |
| Required return | 9.0% |
| Expected alpha | +2.9% |
| Alpha per unit risk (EA/σ) | +0.09 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 44.0% (1σ) | 23.6% implied | broadly consistent with the market's implied uncertainty |
| Mass above spot: scenarios vs our own MC | 63.0% | 53.0% | the two expressions of our own view agree |
| Realised scenario frequency | 59 dated anchors | — | 59 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $71.47.
Factor Exposures
Cross-sectional percentiles over 928 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 32 | AI | 58 | |
| Value | 31 | Cloud | 54 | |
| Quality | 48 | Semis | 65 | |
| Momentum | 88 | Consumer | 66 | |
| Low-Vol | 56 | Rates | 32 | |
| USD | 50 | |||
| Energy | 72 |
Market interaction: correlation vs SPY +0.57, vs QQQ +0.43 (trailing ~1y daily returns).
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies +11% vs spot
- Monte Carlo median implies +2% vs spot
- Justified P/B value implies -42% vs spot
- Bear case (Structural — Credit Cycle / NIM Compression / Regulation) downside is -51% vs spot
- Net: the valuation anchor itself sits 10.6% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| SBC dilution | 0.4%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $7.9B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $8.3B | company guidance | Company guidance | Medium | Forecast, SoP |
| FY+1 guided EPS | $5.11 | company guidance | Company guidance | Medium | Forward P/E, scenarios |
| Consensus FY EPS | $5.2911 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.426B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $-38.103B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| SBC dilution | 0.4%/yr | house estimate | From SBC/revenue | Medium | PWEV, MC, DCF (charged once) |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.21.0 |
| Analysis as-of | 2026-10-13 (prices 2026-10-12) |
| Narrative authorship | claude-opus-5 · Claude Code, supervised, drafted 2026-08-16 |
| Human review | Marinus 2026-08-16 |
| Evidence | 8/8 load-bearing inputs sourced; 13/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF inputs (WACC, terminal multiple) are not applicable to this name's valuation adapter; triangulation leans 34% on DCF, 33% on PWEV, 20% on the Monte Carlo median, 13% on peer-implied value.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-10-12 | Price, market cap, EV, forward P/E | Alpha Vantage 2026-10-12 |
| MCH engine — trailing 52 weeks of daily bars | derived | 2026-10-12 | 52-week range (intraday high and low over the trailing year of the stock's own daily bars) | trailing 52 weeks of own daily bars (intraday high/low, 2025-10-13 to 2026-10-09, 250 sessions) |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-10-12 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-10-12 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-10-12 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-10-12 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-10-12 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-10-12 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-10-12 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-10-12 | Segment revenue and multiple; model margin = gross margin − the calibrated opex ratio (not a reported margin) | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-10-12 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-10-12 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personal financial advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Analysis quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.